Skip To Main Content
  • Resource
  • BR1DGE
  • Monitoring
  • Staging
  • Infographic

Monitoring Individuals with IAb Positive Status

Explore how clinical outcomes are impacted by screening and monitoring

Learning Objectives

  • Understand the benefits of early identification and monitoring of individuals with positive islet autoantibody status

Summary

Individuals with positive islet autoantibody (IAb) status can be identified early via IAb screening. Individuals who test positive for IAbs include those who are at risk of developing presymptomatic T1D (Stages 1 and 2) (1 IAb) or have presymptomatic T1D (Stage 1 or 2) (≥2 IAbs).

Early identification and subsequent monitoring of individuals with positive IAb status can provide time to prepare for the future. Screening and monitoring can lead to beneficial clinical outcomes at onset of Stage 3 T1D and beyond.

MAT-GLB-2405124-1.0 - 12/2024